MHC class I antigens and immune surveillance in transformed cells
- PMID: 17241907
- DOI: 10.1016/S0074-7696(07)56005-5
MHC class I antigens and immune surveillance in transformed cells
Abstract
MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic activity of natural killer (NK) cells. In this review we discuss the role of MHC class I antigens in the recognition and elimination of transformed cells and in the generation of tumor immune escape routes when MHC class I losses occur in tumors. The different altered MHC class I phenotypes and their distribution in different human tumors are the main topic of this review. In addition, molecular defects that underlie MHC alterations in transformed cells are also described in detail. Future research directions in this field are also discussed, including the laboratory analysis of tumor MHC class I-negative variants and the possible restoration of MHC class I expression.
Similar articles
-
MHC class I antigens, immune surveillance, and tumor immune escape.J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290. J Cell Physiol. 2003. PMID: 12704644 Review.
-
Immune selection in murine tumors. Ph.d thesis.APMIS Suppl. 2003;(106):1-46. APMIS Suppl. 2003. PMID: 12739251
-
Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.Exp Hematol. 1996 Sep;24(11):1275-9. Exp Hematol. 1996. PMID: 8862437
-
MHC class I down-regulation: tumour escape from immune surveillance? (review).Int J Oncol. 2004 Aug;25(2):487-91. Int J Oncol. 2004. PMID: 15254748 Review.
-
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.Nat Med. 2006 Apr;12(4):417-24. doi: 10.1038/nm1381. Epub 2006 Mar 19. Nat Med. 2006. PMID: 16550190
Cited by
-
The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies.Front Oncol. 2024 Feb 19;14:1308709. doi: 10.3389/fonc.2024.1308709. eCollection 2024. Front Oncol. 2024. PMID: 38440231 Free PMC article. Review.
-
Epithelial recognition and elimination against aberrant cells.Semin Immunopathol. 2024 Jan;45(4-6):521-532. doi: 10.1007/s00281-024-01001-0. Epub 2024 Feb 27. Semin Immunopathol. 2024. PMID: 38411739 Review.
-
Association of HLA-A, B, and C alleles and cancer susceptibility in 179 solid malignancies.Am J Transl Res. 2023 Sep 15;15(9):5642-5652. eCollection 2023. Am J Transl Res. 2023. PMID: 37854217 Free PMC article.
-
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation.J Immunol. 2023 Aug 15;211(4):693-705. doi: 10.4049/jimmunol.2100793. J Immunol. 2023. PMID: 37395687 Free PMC article.
-
The dichotomous role of immunoproteasome in cancer: Friend or foe?Acta Pharm Sin B. 2023 May;13(5):1976-1989. doi: 10.1016/j.apsb.2022.11.005. Epub 2022 Nov 5. Acta Pharm Sin B. 2023. PMID: 37250147 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials